|[January 23, 2014]
16th Annual BIO CEO & Investor Conference to Highlight 2014 Biotech Outlook, Timely Business Development Issues and Hot Therapeutic Topics
WASHINGTON --(Business Wire)--
Industry Organization (BIO) today announces plenary sessions,
Business Roundtables and Therapeutic Workshops selected for the 16th
annual BIO CEO & Investor Conference. Moderators and panelists
for this premier represent industry thought leaders, academics and
biopharma executives. The conference is to be held in New York City,
February 10-11, 2014, and is the largest independent investor conference
focused on established and emerging publicly traded and select private
"Given the outstanding performance of biotech equities over the past few
years, we see a surge in investor interest in our sector as evidenced by
the uptick in pre-event investor registration for our exclusive event.
The BIO CEO & Investor Conference serves a vital role in bringing
industry leaders together and generating the investment support that
helps to fuel groundbreaking R&D and ultimately breakthrough
technologies," said BIO President & CEO Jim Greenwood. "This year's
program will feature biotech, pharma and Wall Street leaders sharing
their candid insights on what to expect in 2014 and beyond."
In addition to the five Fireside
Chats with top biopharma CEOs, the BIO CEO & Investor Conference
will feature timely discussions with industry experts on a variety of
The Plenary Sessions will address the upcoming year, using the results
of the joint BIO / ISI (News - Alert) published Buy-Side Perception Study as well as
dissect the new capital market environment's impact on fundraising.
Plenary sessions include:
Business Roundtables include:
Therapeutic Workshops include:
In addition, attendees have access to BIO's
One-on-One Partnering™ System which provides the opportunity to
arrange meetings between and among investors, companies and industry
executives. Further, the event features presentations from more than 150
leading biotechnology and pharmaceutical companies.
Qualified institutional and venture investors whose primary activity is
direct investment in research and development companies are eligible for complimentary
registration. Equity research analysts from investment banking
institutions also qualify as investors.
registration also is complimentary for credentialed members of the
media. All registrations are subject to verification of credentials.
BIO is pleased to recognize the leadership provided by the sponsors of
the BIO CEO & Investor Conference, including supporting banks H.C.
Wainwright & Co., JMP Securities (News - Alert), Lazard, Leerink Partners LLC and ROTH
Capital Partners, LLC.
BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW
is BIO's blog chronicling "innovations transforming our world" and the
BIO Newsletter is the organization's bi-weekly email newsletter." Subscribe
to the BIO Newsletter.
Upcoming BIO Events
CEO & Investor Conference
February 10-11, 2014
Asia International Conference
April 8-9, 2014
Congress on Industrial Biotechnology
May 12-15, 2014
June 23-26, 2014
San Diego, CA (News - Alert)
September 16-18, 2014
Sioux Falls, SD
[ Back To TMCnet.com's Homepage ]